Safeguarding adults in care homes
Everything NICE has said on safeguarding adults in care homes in an interactive flowchart.
Everything NICE has said on safeguarding adults in care homes in an interactive flowchart.
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
ES33 Product overview The content of this evidence summary was up to date in February 2021. New evidence may have been
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
Everything NICE has said on ear, nose and throat conditions in an interactive flowchart
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
Everything NICE has said on endocrine, nutritional and metabolic conditions in an interactive flowchart
Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12...
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...
Everything NICE has said on bladder cancer in adults in an interactive flowchart
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
Everything NICE has said on improving the experience of care for people using adult NHS mental health services in an interactive flowchart
NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness
Everything NICE has said on identifying and managing common mental health disorders in adults in primary care in an interactive flowchart
NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery
NICE has developed a medtech innovation briefing (MIB) on moorLDLS-BI for burn depth assessment
Everything NICE has said on transition between community or care home and inpatient mental health settings in an interactive flowchart
Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart
Everything NICE has said on sarcoma in an interactive flowchart
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
Everything NICE has said on low back pain and sciatica in an interactive flowchart
Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart
Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart
Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
NICE has developed a medtech innovation briefing (MIB) on URO17 for detecting bladder cancer
Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart
Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
Everything NICE has said on caesarean section in an interactive flowchart
Everything NICE has said on age-related macular degeneration in an interactive flowchart
NICE has developed a medtech innovation briefing (MIB) on faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection.
NICE has developed a medtech innovation briefing (MIB) on DOAC Dipstick for detecting direct oral anticoagulants
NICE has developed a medtech innovation briefing (MIB) on CytoSorb for reducing risk of bleeding during cardiac surgery
Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart
Everything NICE has said on brain tumours in adults, including cancer, in an interactive flowchart
Everything NICE has said on screening and managing cervical cancer in an interactive flowchart
Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart
Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
NICE has developed a medtech innovation briefing (MIB) on AcQMap for mapping the heart atria to target ablation treatment for arrhythmias
NICE has developed a medtech innovation briefing (MIB) on Accuro for guiding epidural or spinal anaesthesia
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
Everything NICE has said on abortion care in an interactive flowchart.
Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.
Recommendation ID NG186/2 Question What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring